The MPRO Clone 2.1 cells were with or without treatment of CXCR2 antagonist, SCH 527123, for 4 hours. Higher Levels of CXCR2 Ligands To assess the relationship between the IL-17/CXCR2 axis and chemotherapy resistance, the murine breast cancer cell collection Cl66, cells resistant to doxorubicin (Cl66-Dox), or cells resistant to paclitaxel (Cl66-Pac) were used. The … Continue reading The MPRO Clone 2